Predictors of Successful Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Management of Ovarian Cancer. Authors : Claudia Marchetti, MD, PhD , Gwenael Ferron, MD , et al. JCO Oncology Practice, Nov 24, 2025. DOI: 10.1200/OP-25-00469 What the study was about The study focused on people with ovarian cancer who are given neoadjuvant chemotherapy (NACT) — meaning chemotherapy before attempting surgery — with the goal of achieving a complete interval cytoreducti
